CSPIA
TECH icon

Cary Street Partners Investment Advisory’s Bio-Techne TECH Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15
Closed -$1.02K – 1686
2023
Q3 		$1.02K Buy
+15
New +$1.19K ﹤0.01% 1734

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Cary Street Partners Investment Advisory's TECH Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Bio-Techne (TECH) in Q4 2023, closing a stake of 15 shares — an estimated $1.02K sold.

Cary Street Partners Investment Advisory first reported a position in TECH in Q3 2023 and held it in 1 quarter. The position peaked at $1.02K in Q3 2023. 531 funds tracked by Wall St. Rank hold TECH as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Bio-Techne position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 15 Bio-Techne shares in Q4 2023, an estimated $1.02K.
  • Cary Street Partners Investment Advisory first reported a position in Bio-Techne in Q3 2023 and held it in 1 quarter.
  • Cary Street Partners Investment Advisory's Bio-Techne position peaked at $1.02K in Q3 2023.
  • 531 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.